Skip to main content

News

News
09/18/2025
Jessica Garlewicz
Interventions aimed at improving food access may play a key role in mitigating liver disease burden in vulnerable communities.
Interventions aimed at improving food access may play a key role in mitigating liver disease burden in vulnerable communities.
Interventions aimed at improving...
09/18/2025
Gastroenterology
News
09/18/2025
Jessica Garlewicz
The dual mechanism of action and resistance profile of rifasutenizol mark it as a promising agent in the evolving landscape of H. pylori treatment.
The dual mechanism of action and resistance profile of rifasutenizol mark it as a promising agent in the evolving landscape of H. pylori treatment.
The dual mechanism of action and...
09/18/2025
Gastroenterology
News
09/18/2025
Jessica Garlewicz
For gastroenterologists, this study underscores the importance of recognizing restrictive eating patterns in DGBI and coordinating multidisciplinary management to address both GI and psychosocial factors.
For gastroenterologists, this study underscores the importance of recognizing restrictive eating patterns in DGBI and coordinating multidisciplinary management to address both GI and psychosocial factors.
For gastroenterologists, this...
09/18/2025
Gastroenterology
News
09/18/2025
Jessica Garlewicz
For gastroenterologists, these findings underscore the value of addressing lifestyle and technology use as part of routine care.
For gastroenterologists, these findings underscore the value of addressing lifestyle and technology use as part of routine care.
For gastroenterologists, these...
09/18/2025
Gastroenterology
Research Highlights
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
Research Highlights
09/05/2025
Rebecca Mashaw
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the...
09/05/2025
Gastroenterology
Research Highlights
09/05/2025
Rebecca Mashaw
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
09/05/2025
Gastroenterology
Research Highlights
09/04/2025
Jessica Garlewicz
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians...
09/04/2025
Gastroenterology
News
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology